Skip to main content
padlock icon - secure page this page is secure

Long‐term follow‐up of patients with multiple myeloma treated with total body irradiation—Melphalan conditioning

Buy Article:

$59.00 + tax (Refund Policy)

Since a study published in 2002 showed a survival advantage of melphalan‐only conditioning for stem cell transplantation (HSCT) over melphalan‐total body irradiation (mel‐TBI) in patients with multiple myeloma (MM), most centers abandoned mel‐TBI. Mel‐TBI causes more early toxicity and is more complicated to administer, but we speculated it may result in longer term survival with radiation as an independent treatment modality. Therefore, we analyzed the long‐term outcome of patients with MM who received mel‐TBI as part of conditioning at our center.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Autologous stem cell transplantation; Conditioning; Multiple myeloma; Total body irradiation

Document Type: Research Article

Publication date: July 1, 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more